Advertisement

The Scientist

» biotechnology, immunology and neuroscience

Most Recent

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | July 1, 2015

Stoned, Anxious, The Deeper Genome, and Testosterone.

0 Comments

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

A new test that scans for the Ebola virus with just a fingerprick could be a practical diagnostic for use in West Africa.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

0 Comments

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: New Human Brain Language Map

New Human Brain Language Map

By | June 26, 2015

Researchers find that Wernicke’s area, thought to be the seat of language comprehension in the human brain for more than a century, is not.

0 Comments

image: Week in Review: June 22–26

Week in Review: June 22–26

By | June 26, 2015

Neanderthal-human hybrid discovered; the neurobiology of fear behavior; and an insulin patch that responds to high glucose levels in mice

0 Comments

image: The Brain on Fear

The Brain on Fear

By | June 25, 2015

Scientists uncover the neurons in the mouse brain responsible for linking the sight of a looming object to scared behavior.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

Advertisement
TECA Corporation
TECA Corporation

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Neanderthal-Human Hybrid Unearthed
  3. Sex Differences in Pain Pathway
  4. Antibiotics and the Gut Microbiome
Advertisement
The Scientist